Clinical trial • Phase I • Oncology
ZL-1310 for Small cell lung cancer
Phase I trial of ZL-1310 for Small cell lung cancer. adaptive. 89 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Small cell lung cancer
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 31-07-2024
- First CTIS Authorization Date
- 31-10-2024
Trial design
adaptive Phase I trial across 11 sites in Spain.
- Adaptive
- Yes
- Single Multiple Or Escalation Dose Combined
- Yes
- Target Sample Size
- 89
- Trial Duration For Participant
- 1255
Recruitment
- Planned Sample Size
- 89
- Recruitment Window Months
- 41
Geography
- Total Number Of Sites
- 11
- Total Number Of Participants
- 89
Spain
- Earliest CTIS Part Ii Submission Date
- 30-07-2024
- Latest Decision Or Authorization Date
- 13-04-2026
- Processing Time Days
- 622
- Number Of Sites
- 11
- Number Of Participants
- 80
Sites
- Site Name
- Hospital Universitario 12 De Octubre
- Department Name
- Oncology Department
- Contact Person Name
- Luis Paz-Ares Rodriguez
- Contact Person Email
- lpazaresr@seom.org
- Site Name
- Hospital Universitario Ramon Y Cajal
- Department Name
- Oncology Department
- Contact Person Name
- Maria Eugenia Olmedo Garcia
- Contact Person Email
- maruolmedogarcia@hotmail.com
- Site Name
- Hospital Hm Nou Delfos
- Department Name
- Oncology Department
- Contact Person Name
- Tatiana Hernandez Guerrero
- Contact Person Email
- tatiana.hernandez@start-barcelona.com
- Site Name
- Hospital Clinico Universitario De Valencia
- Department Name
- Oncology Department
- Contact Person Name
- Valentina Gambardella
- Contact Person Email
- vgambardella@incliva.es
- Site Name
- Hospital Universitario Regional De Malaga
- Department Name
- Oncology Department
- Contact Person Name
- Manuel Cobo Dols
- Contact Person Email
- manuelcobodols@yahoo.es
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- Oncology Department
- Contact Person Name
- Juan Jose Soto Castillo
- Contact Person Email
- juanj.soto@startmadrid.com
- Site Name
- Hospital Universitario Quironsalud Madrid
- Department Name
- Oncology Department
- Contact Person Name
- Valentina Boni
- Contact Person Email
- vboni@nextoncology.eu
- Site Name
- Vall D Hebron Institute Of Oncology
- Department Name
- Oncology Department
- Contact Person Name
- Pedro Filipe Simoes Da Rocha
- Contact Person Email
- pedrorocha@vhio.net
- Site Name
- Hospital Universitario Y Politecnico La Fe
- Department Name
- Oncology Department
- Contact Person Name
- Oscar Jose Juan Vidal
- Contact Person Email
- ojjuanv@seom.org
- Site Name
- University Hospital Virgen Del Rocio S.L.
- Department Name
- Oncology Department
- Contact Person Name
- Alejandro Falcon Gonzalez
- Contact Person Email
- alejandro.falcon.sspa@juntadeandalucia.es
- Site Name
- Hospital Universitario Virgen De La Macarena
- Department Name
- Oncology Department
- Contact Person Name
- David Vicente Baz
- Contact Person Email
- david.vicente.sspa@juntadeandalucia.es
Sponsor
Primary sponsor
- Full Name
- Zai Lab (US) LLC
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United States
Investigational products
- Investigational Product Name
- ZL-1310
Related trials
Other published trials that may interest you.